Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07140692 · ClinicalTrials.gov registry record · NA
Effectiveness AND Safety Assessment OF THE Vista Vitrectomy Probe
A NA study of Vitreous Floaters and Vitreous Opacities, sponsored by The Eye Centers of Racine and Kenosha.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07140692: Completed NA study of Vitreous Floaters and Vitreous Opacities, sponsored by The Eye Centers of Racine and Kenosha.
NCT07140692 is a NA study of Vitreous Floaters and Vitreous Opacities that has completed, run by The Eye Centers of Racine and Kenosha. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07140692, a NA study of Vitreous Floaters and Vitreous Opacities, has completed, sponsored by The Eye Centers of Racine and Kenosha.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Vitreous opacities or floaters are a common ocular condition that can cause significant impairment in vision-related quality of life (QoL) in some patients. Vitrectomy involves the surgical removal of vitreous humour, the transparent jelly, from inside the eye that contains vitreous opacities and floaters. The present post-market clinical assessment study aims to assess the safety and effectiveness performance of the Vista 1-Step vitrectomy probe in adult pseudophakic patients with visually symptomatic opacities.
Conditions Studied
Interventions
- DEVICE Vitrectomy
Study Locations (1)
Wisconsin
- The Eye Centers of Racine & Kenosha - Kenosha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-09-14 |
| Est. Completion | 2024-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07140692
The ClinicalTrials.gov registry entry for NCT07140692 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Eye Centers of Racine and Kenosha, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Vitreous Floaters appearing as the primary indexed condition, and to 1 intervention - of which Vitrectomy is the first listed.
NCT07140692 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT07140692 about?
NCT07140692 is a clinical study titled "Effectiveness AND Safety Assessment OF THE Vista Vitrectomy Probe". Vitreous opacities or floaters are a common ocular condition that can cause significant impairment in vision-related quality of life (QoL) in some patients. Vitrectomy involves the surgical removal of vitreous humour, the transparent jelly, from inside the eye that contains vitreous opacities and fl...
What is the current status of trial NCT07140692?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-09-14. Estimated completion is 2024-07-01.
What conditions does trial NCT07140692 study?
This clinical trial studies the following conditions: Vitreous Floaters, Vitreous Opacities.
What interventions are being tested in trial NCT07140692?
The interventions under investigation include: Vitrectomy (DEVICE).
Who is sponsoring clinical trial NCT07140692?
This trial is sponsored by The Eye Centers of Racine and Kenosha, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07140692 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.